Chondrocytes in specific areas of the chick sternum have different dev
elopmental fates, Cephalic chondrocytes become hypertrophic and secret
e type X collagen into the extracellular matrix prior to bone depositi
on, Middle and caudal chondrocytes remain cartilaginous throughout dev
elopment and continue to secrete collagen types II, IX, and XI, The in
teraction of integrin receptors with extracellular matrix molecules ha
s been shown to affect cytoskeleton organization, proliferation, diffe
rentiation, and gene expression in other cell types. We hypothesized t
hat chondrocyte survival and differentiation including the deposition
into interstitial matrix of type X collagen may be integrin receptor m
ediated, To test this hypothesis, a serum-free organ culture sternal m
odel that recapitulates normal development and maintains the three-dim
ensional relationships of the tissue was developed, We examined chondr
ocyte differentiation by five parameters: type X collagen deposition i
nto interstitial matrix, sternal growth, actin distribution, cell shap
e, and cell diameter changes, Additional sterna were analyzed for apop
tosis using a fragmented DNA assay, Sterna were organ cultured with bl
ocking antibodies specific for integrin subunits (alpha 2, alpha 3, or
beta 1). In the presence of anti-beta 1 integrin (25 mu g/ml, clone W
1B10), type X collagen deposition into interstitial matrix and sternal
growth were significantly inhibited, In addition, all chondrocytes we
re significantly smaller, the actin was disrupted, and there was a sig
nificant increase in apoptosis throughout the specimens, Addition of a
nti-alpha 2 (10 mu g/ml, clone P1E6) or anti-alpha 3 (10 mu g/ml, clon
e P1B5) integrin partially inhibited type X collagen deposition into i
nterstitial matrix; however, sternal growth and cell size were signifi
cantly decreased, These data are the first obtained from intact tissue
and demonstrate that the interaction of chondrocytes with extracellul
ar matrix is required for chondrocyte survival and differentiation. (C
) 1997 Wiley-Liss, Inc.